GB1227646A - - Google Patents
Info
- Publication number
- GB1227646A GB1227646A GB1227646DA GB1227646A GB 1227646 A GB1227646 A GB 1227646A GB 1227646D A GB1227646D A GB 1227646DA GB 1227646 A GB1227646 A GB 1227646A
- Authority
- GB
- United Kingdom
- Prior art keywords
- papaverine
- monopapaverine
- june
- salts
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1,227,646. Papaverine salts. LES LABORATOIRES DAUSSE. 20 June, 1969 [24 June, 1968], No. 31427/69. Heading C2C. The invention comprises monopapaverine succinate, papaverine orotate, monopapaverine citrate and papaverine (6-hydroxy-4-methyl-2- oxo-2H.chromen-7-yl)oxyacetate which are prepared by reacting papaverine with the appropriate acid in a molar ratio of essentially 1 :1. Pharmaceutical compositions, suitable for oral and parenteral administration, contain the above acid addition salts and pharmaceutically acceptable carriers or excipients. The compositions may be used to combat spasms and circulatory insufficiencies, especially cerebral circulatory deficiencies.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR156297 | 1968-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1227646A true GB1227646A (en) | 1971-04-07 |
Family
ID=8651555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1227646D Expired GB1227646A (en) | 1968-06-24 | 1969-06-20 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE734305A (en) |
| DE (1) | DE1931238A1 (en) |
| FR (1) | FR1585928A (en) |
| GB (1) | GB1227646A (en) |
| IT (1) | IT1033026B (en) |
| LU (1) | LU58889A1 (en) |
| NL (1) | NL6909643A (en) |
-
1968
- 1968-06-24 FR FR1585928D patent/FR1585928A/fr not_active Expired
-
1969
- 1969-06-09 BE BE734305D patent/BE734305A/xx unknown
- 1969-06-17 LU LU58889D patent/LU58889A1/xx unknown
- 1969-06-17 IT IT1829569A patent/IT1033026B/en active
- 1969-06-20 DE DE19691931238 patent/DE1931238A1/en active Pending
- 1969-06-20 GB GB1227646D patent/GB1227646A/en not_active Expired
- 1969-06-24 NL NL6909643A patent/NL6909643A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1033026B (en) | 1979-07-10 |
| DE1931238A1 (en) | 1970-01-02 |
| LU58889A1 (en) | 1969-11-10 |
| NL6909643A (en) | 1969-12-30 |
| FR1585928A (en) | 1970-02-06 |
| BE734305A (en) | 1969-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| GB1256723A (en) | ||
| GB1210968A (en) | Improvements in or relating to the treatment of gastric ailments | |
| GB1227646A (en) | ||
| GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
| GB1184826A (en) | Substituted Aryloxy Hydroxy Amines | |
| IE35711L (en) | Pharmaceutical compositions | |
| GB1260857A (en) | IMIDAZO-3H-(4,5-b)-PYRIDINE DERIVATIVES | |
| GB1279380A (en) | Improvements in or relating to hydantoins and compositions thereof | |
| GB1317236A (en) | Preparation of 2-aryl-as-triazine-3,5,2h,4h-diones | |
| GB1386927A (en) | Preparations for combatting swine dysentery | |
| GB1169074A (en) | Improvements in or relating to Hepato-Protective Drugs | |
| GB1368251A (en) | Theophylinylmethylethanoic acid ester | |
| GB1342643A (en) | Thioacetanilide derivatives | |
| GB1223062A (en) | Improvements in or relating to new aminoacid derivatives | |
| IE33519B1 (en) | Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process | |
| GB1397675A (en) | Proline compounds | |
| GB1501839A (en) | Pharmaceutical compositions for the inhibition of thrombocyte aggregation | |
| GB1312204A (en) | Pharmaceutical compositions | |
| GB1317099A (en) | 3-sulphamyl-4-chlorobenzoic acid derivatives | |
| GB1414147A (en) | 2,4-dihydro-6-o-chlorophenyl-1h-s-triazolo-4,3-a 1,4- benzodiazepin 1-ones | |
| GB1417323A (en) | Physiologically active xanthine compounds and compositions containing them | |
| IE33520B1 (en) | Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process | |
| GB1173985A (en) | Indole Derivatives | |
| GB1254125A (en) | Pharmaceutical composition suitable for the treatment of certain vascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |